Metabolon Stock

Metabolon develops analytical methods and software for biomarker discovery by using metabolomics.

Sign up today and learn more about Metabolon Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Metabolon Stock

Metabolon is a technology company, develops analytical methods and software for biomarker discovery using metabolomics. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. Metabolon provides a unique, real-time fingerprint of biological system to reveal novel discoveries and realize the promise of precision medicine. The company can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of the disease, medical intervention, diet, or the environment. This deep and comprehensive view of the metabolome provides biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers to some of biology’s most difficult questions. Metabolon was founded in 2000 and headquartered in Durham, North Carolina.

Funding History

August 2003$4.0M
October 2004$5.0M
January 2006$8.0M
March 2008$3.1M
October 2009$6.2M
December 2009$6.0M
August 2011$13.1M
January 2014$15.0M
March 2015$5.0M
August 2016$15.0M
August 2018$7.3M
August 2020$72.0M


Chief Business Officer

Rohan F. Hastie

Chief Executive Officer

Rohan F. Hastie

Board of Directors

Tom Caskey

Member of Scientific Advisory Board

Paul Schimmel

Scientific Advisory Board

Arul Chinnaiyan

Board of Directors

John Oxaal

Board of Director

Christopher W. Kersey

Chief Scientific Officer

Rangaprasad Sarangarajan

Board of Directors

Santo Costa

Interim Chief Financial Officer

John T. Kurtzweil

Board of Directors

Rudy Howard

Chief Financial Officer

Gerry Haines


vcnewsdaily - Jan, 25 2023

Metabolon Secures $25M

genomeweb - Oct, 28 2021

Metabolon Microbiome SmartPanel

strictlyvc - Dec, 31 2016

StrictlyVC: December 6, 2016

venturebeat - Dec, 8 2016

Tech to stop the diabetes tidal wave

businesswire - Sep, 29 2015

BDCA Venture Reports Q1 2015 Results

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: